6mvm
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==LasR LBD L130F:3OC14HSL complex== | ==LasR LBD L130F:3OC14HSL complex== | ||
- | <StructureSection load='6mvm' size='340' side='right' caption='[[6mvm]], [[Resolution|resolution]] 1.90Å' scene=''> | + | <StructureSection load='6mvm' size='340' side='right'caption='[[6mvm]], [[Resolution|resolution]] 1.90Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6mvm]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MVM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6MVM FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6mvm]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Pseab Pseab]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6MVM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6MVM FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K4G:3-oxo-N-[(3S)-2-oxooxolan-3-yl]tetradecanamide'>K4G</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K4G:3-oxo-N-[(3S)-2-oxooxolan-3-yl]tetradecanamide'>K4G</scene></td></tr> | ||
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">lasR, PA14_45960 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=208963 PSEAB])</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6mvm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mvm OCA], [http://pdbe.org/6mvm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6mvm RCSB], [http://www.ebi.ac.uk/pdbsum/6mvm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6mvm ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6mvm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6mvm OCA], [http://pdbe.org/6mvm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6mvm RCSB], [http://www.ebi.ac.uk/pdbsum/6mvm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6mvm ProSAT]</span></td></tr> | ||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
- | + | Bacteria use a cell-cell communication process called quorum sensing to coordinate collective behaviors. Quorum sensing relies on production and group-wide detection of extracellular signal molecules called autoinducers. Here, we probe the activity of the Pseudomonas aeruginosa LasR quorum-sensing receptor using synthetic agonists based on the structure of the native homoserine lactone autoinducer. The synthetic compounds range from low to high potency, and agonist activity tracks with the ability of the agonist to stabilize the LasR protein. Structural analyses of the LasR ligand binding domain complexed with representative synthetic agonists reveal two modes of ligand binding, one mimicking the canonical autoinducer binding arrangement, and the other with the lactone head group rotated approximately 150 degrees . Iterative mutagenesis combined with chemical synthesis reveals the amino acid residues and the chemical moieties, respectively, that are key to enabling each mode of binding. Simultaneous alteration of LasR residues Thr75, Tyr93, and Ala127 converts low-potency compounds into high-potency compounds and converts ligands that are nearly inactive into low-potency compounds. These results show that the LasR binding pocket displays significant flexibility in accommodating different ligands. The ability of LasR to bind ligands in different conformations, and in so doing, alter their potency as agonists, could explain the difficulties that have been encountered in the development of competitive LasR inhibitors. | |
- | + | An Autoinducer Analogue Reveals an Alternative Mode of Ligand Binding for the LasR Quorum-Sensing Receptor.,Paczkowski JE, McCready AR, Cong JP, Li Z, Jeffrey PD, Smith CD, Henke BR, Hughson FM, Bassler BL ACS Chem Biol. 2019 Mar 15;14(3):378-389. doi: 10.1021/acschembio.8b00971. Epub, 2019 Mar 4. PMID:30763066<ref>PMID:30763066</ref> | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
Line 20: | Line 21: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Pseab]] | ||
[[Category: Bassler, B L]] | [[Category: Bassler, B L]] | ||
[[Category: Paczkowski, J E]] | [[Category: Paczkowski, J E]] | ||
[[Category: Transcription]] | [[Category: Transcription]] | ||
[[Category: Transcriptional activator protein]] | [[Category: Transcriptional activator protein]] |
Revision as of 06:11, 10 October 2019
LasR LBD L130F:3OC14HSL complex
|